AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to find subtle tissue changes that allow the cancer to be detected long before it becomes visible to the human eye.

Previous research has demonstrated that AI is able to detect tissue changes indicative of cancer. In the current study, published in Scientific Reports, the researchers show that AI can also find cancers missed by pathologists.

"The study has been nicknamed the ‘missed study’, as the goal of finding the cancer was ‘missed’ by the pathologists. We have now shown that with the help of AI, it is possible to find signs of prostate cancer that were not observed by pathologists in more than 80 per cent of samples from men who later developed cancer," says Carolina Wählby, who led the AI development in the study.

The project is based on a collaboration with Umeå University, where the researchers collected samples from men called for sample-taking over a number of years. All 232 men in the study were assessed as healthy when their biopsies were examined by pathologists. After less than two-and-a-half years, half of the men in the study had developed aggressive prostate cancer, while the rest were still cancer-free eight years later.

As all tissue samples were initially assessed as negative, the researchers developed a new way to train the AI tool. It was trained by analysing each biopsy image bit by bit, with the assumption that abnormal patterns ought to be present somewhere in the biopsies that came from patients who later developed aggressive cancer, while the other images should not contain such patterns. The AI was then tested on an independent set of images.

"When we looked at the patterns that the AI ranked as informative, we saw changes in the tissue surrounding the glands in the prostate - changes also observed in other studies. This shows that AI analysis of routine biopsies can detect subtle signs indicating clinically significant prostate cancer before it becomes obvious to a pathologist," says Wählby.

The researchers suggest that this type of analysis could be used to decide how soon men who have been assessed as healthy should be followed up. The imaging data collected and the researchers’ methods are openly available for further research and development.

Chelebian E, Avenel C, Järemo H, Andersson P, Bergh A, Wählby C.
Discovery of tumour indicating morphological changes in benign prostate biopsies through AI.
Sci Rep. 2025 Aug 21;15(1):30770. doi: 10.1038/s41598-025-15105-6

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

AI Analysis of Colonoscopy Improves Asse…

In a new study, artificial intelligence (AI) matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn’s disease patients. The results, published in Clinical Gastroenterology...

International Study Reveals Sex and Age …

An international research team led by Assistant Professor Zhiyu Wan from ShanghaiTech University has recently published groundbreaking findings in the journal Health Data Science, highlighting biases in multimodal large language...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...